NeuroOne Medical Technologies Corporation Share-based Payment Arrangement, Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Share-based Payment Arrangement, Expense of $352.78 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for the quarter ending 2026-06-30 was $352.78K, a 11.41% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for the quarter ending 2026-03-31 was $342.13K, a 36.76% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for the quarter ending 2025-12-31 was $359.25K, a 5.90% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for the quarter ending 2025-09-30 was $358.56K, a 5.34% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for fiscal 2025 was $1.26M, a 5.94% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for fiscal 2024 was $1.34M, a 21.62% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for fiscal 2023 was $1.11M, a 16.71% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation share-based payment arrangement, expense for fiscal 2022 was $947.21K, a 47.18% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $352.78K 10-Q · filed 2026-08-13 | $694.91K derived: sum of 2 quarters · filed 2026-08-13 | $1.05M 10-Q · filed 2026-08-13 | $1.41M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $342.13K 10-Q/A · filed 2026-06-12 | $701.39K 10-Q/A · filed 2026-06-12 | $1.06M derived: sum of 3 quarters · filed 2026-06-12 | $1.38M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $359.25K 10-Q · filed 2026-02-17 | $717.82K derived: sum of 2 quarters · filed 2026-02-17 | $1.03M derived: sum of 3 quarters · filed 2026-08-13 | $1.28M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $358.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $675.21K derived: sum of 2 quarters · filed 2026-08-13 | $925.38K derived: sum of 3 quarters · filed 2026-08-13 | $1.26M 10-K · filed 2025-12-17 | |
| 2025-06-30 | $316.65K 10-Q · filed 2026-08-13 | $566.82K derived: sum of 2 quarters · filed 2026-08-13 | $906.05K 10-Q · filed 2026-08-13 | $1.25M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $250.17K 10-Q/A · filed 2026-06-12 | $589.39K 10-Q/A · filed 2026-06-12 | $929.76K derived: sum of 3 quarters · filed 2026-06-12 | $1.27M derived: sum of 4 quarters · filed 2026-06-12 | |
| 2024-12-31 | $339.22K 10-Q · filed 2026-02-17 | $679.60K derived: sum of 2 quarters · filed 2026-02-17 | $1.02M derived: sum of 3 quarters · filed 2026-02-17 | $1.38M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | $340.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $678.98K derived: sum of 2 quarters · filed 2025-12-17 | $1.04M derived: sum of 3 quarters · filed 2025-12-17 | $1.34M 10-K · filed 2025-12-17 | |
| 2024-06-30 | $338.61K 10-Q · filed 2025-08-14 | $695.47K derived: sum of 2 quarters · filed 2025-08-14 | $1.00M 10-Q · filed 2025-08-14 | $1.28M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $356.86K 10-Q · filed 2025-05-13 | $665.50K 10-Q · filed 2025-05-13 | $936.74K derived: sum of 3 quarters · filed 2025-05-13 | $1.23M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $308.64K 10-Q · filed 2025-02-12 | $579.88K derived: sum of 2 quarters · filed 2025-02-12 | $876.29K derived: sum of 3 quarters · filed 2025-02-12 | $1.11M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | $271.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $567.65K derived: sum of 2 quarters · filed 2024-12-17 | $805.28K derived: sum of 3 quarters · filed 2024-12-17 | $1.11M 10-K · filed 2024-12-17 | |
| 2023-06-30 | $296.40K 10-Q · filed 2024-08-14 | $534.03K derived: sum of 2 quarters · filed 2024-08-14 | $834.21K 10-Q · filed 2024-08-14 | $1.09M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $237.63K 10-Q · filed 2024-05-14 | $537.81K 10-Q · filed 2024-05-14 | $793.68K derived: sum of 3 quarters · filed 2024-05-14 | $1.05M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $300.18K 10-Q · filed 2024-02-13 | $556.06K derived: sum of 2 quarters · filed 2024-02-13 | $811.61K derived: sum of 3 quarters · filed 2024-02-13 | $1.04M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $255.88K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $511.42K derived: sum of 2 quarters · filed 2023-12-15 | $744.14K derived: sum of 3 quarters · filed 2023-12-15 | $947.21K 10-K · filed 2023-12-15 | |
| 2022-06-30 | $255.55K 10-Q · filed 2023-08-14 | $488.26K derived: sum of 2 quarters · filed 2023-08-14 | $691.34K 10-Q · filed 2023-08-14 | $1.03M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $232.72K 10-Q · filed 2023-05-12 | $435.79K 10-Q · filed 2023-05-12 | $777.95K derived: sum of 3 quarters · filed 2023-05-12 | $1.66M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $203.07K 10-Q · filed 2023-02-13 | $545.23K derived: sum of 2 quarters · filed 2023-02-13 | $1.42M derived: sum of 3 quarters · filed 2023-02-13 | $1.75M derived: sum of 4 quarters · filed 2023-02-13 | |
| 2021-09-30 | $342.16K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $1.22M derived: sum of 2 quarters · filed 2022-12-22 | $1.55M derived: sum of 3 quarters · filed 2022-12-22 | $1.79M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $878.85K 10-Q · filed 2021-08-13 | $1.21M derived: sum of 2 quarters · filed 2021-08-13 | $1.45M 10-Q · filed 2021-08-13 | $1.78M derived: sum of 4 quarters · filed 2022-05-31 | |
| 2021-03-31 | $326.36K 10-Q · filed 2021-05-14 | $572.19K 10-Q · filed 2021-05-14 | $905.02K derived: sum of 3 quarters · filed 2022-05-31 | $1.29M derived: sum of 4 quarters · filed 2022-05-31 | |
| 2020-12-31 | $245.83K 10-Q · filed 2022-02-14 | $578.66K derived: sum of 2 quarters · filed 2022-05-31 | $962.34K derived: sum of 3 quarters · filed 2022-05-31 | $1.49M derived: sum of 4 quarters · filed 2022-05-31 | |
| 2020-09-30 | $332.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | $716.51K derived: sum of 2 quarters · filed 2022-05-31 | $1.25M derived: sum of 3 quarters · filed 2022-05-31 | $1.84M 10-K/A · filed 2022-05-31 | |
| 2020-06-30 | $383.68K 10-Q · filed 2021-08-13 | $915.46K derived: sum of 2 quarters · filed 2021-08-13 | $1.50M 10-Q · filed 2021-08-13 | $1.57M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $531.78K 10-Q · filed 2021-05-14 | $1.12M 10-Q · filed 2021-05-14 | $1.19M derived: sum of 3 quarters · filed 2021-05-14 | $1.42M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $587.68K 10-Q · filed 2021-02-16 | $658.14K derived: sum of 2 quarters · filed 2021-02-16 | $890.23K derived: sum of 3 quarters · filed 2021-02-16 | $960.45K derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | $70.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-09 | $302.55K derived: sum of 2 quarters · filed 2020-12-09 | $372.77K derived: sum of 3 quarters · filed 2020-12-09 | $491.75K 10-K · filed 2020-12-09 | |
| 2019-06-30 | $232.09K 10-Q · filed 2020-08-13 | $302.31K derived: sum of 2 quarters · filed 2020-08-13 | $421.29K 10-Q · filed 2020-08-13 | $533.46K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $70.22K 10-Q · filed 2020-05-14 | $189.20K 10-Q · filed 2020-05-14 | $301.37K derived: sum of 3 quarters · filed 2020-05-14 | $420.88K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $118.98K 10-Q · filed 2020-02-14 | $115.00K 10-Q · filed 2019-02-14 | $231.15K derived: sum of 2 quarters · filed 2020-02-14 | $350.66K derived: sum of 3 quarters · filed 2020-02-14 | $605.10K derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | $112.17K derived: 10-KT 9 month − 10-Q 6 month · filed 2019-03-18 | $231.68K derived: sum of 2 quarters · filed 2019-08-14 | $486.12K 10-K · filed 2019-12-20 | $486.12K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-06-30 | $119.51K 10-Q · filed 2019-08-14 | $373.95K 10-Q · filed 2018-08-13 | $373.95K 10-Q · filed 2019-08-14 | $438.89K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $254.44K 10-Q · filed 2019-05-10 | $254.44K 10-Q · filed 2019-05-10 | $319.38K derived: sum of 3 quarters · filed 2019-05-10 | $331.23K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-KT 9 month · filed 2018-04-16 | $64.94K derived: sum of 2 quarters · filed 2018-04-16 | $76.79K derived: sum of 3 quarters · filed 2018-08-13 | $76.79K 10-K · filed 2018-04-16 | |
| 2017-09-30 | $64.94K 10-Q · filed 2017-11-14 | $76.79K derived: sum of 2 quarters · filed 2018-08-13 | $76.79K 10-KT · filed 2019-03-18 | ||
| 2017-06-30 | $11.85K 10-Q · filed 2018-08-13 | $11.85K 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |